Free access supported by contributions and sponsoring — share your knowledge or support us financially
Search / Compare / Validate Lab equipment & Methods

Isobutylmethylxanthine

Manufactured by Merck Group
Sourced in United States, Germany, United Kingdom, France, Japan, Sao Tome and Principe, China, Macao, Denmark, Canada, Switzerland, Brazil, Spain, India
About the product

Isobutylmethylxanthine is a laboratory reagent used primarily as a phosphodiesterase inhibitor in cell culture and biochemical research applications. It is a synthetic compound that can modulate the activity of cyclic nucleotide signaling pathways. The core function of Isobutylmethylxanthine is to inhibit the breakdown of cyclic AMP and cyclic GMP, which can lead to increased levels of these important signaling molecules in cells.

Automatically generated - may contain errors

Market Availability & Pricing

Isobutylmethylxanthine is an active pharmaceutical ingredient commercially available from Merck Group. It is sold through authorized distributors, but specific pricing and availability details are not currently provided on the manufacturer's website.

Need Operating Instructions, SDS, or distributor details? Just ask our AI Agent.

Is this product still available?

Get pricing insights and sourcing options

Product FAQ

873 protocols using «isobutylmethylxanthine»

1

Multilineage Differentiation Assay for MSCs

2025
Differentiation was performed for 12 samples (n = 6 each for the FC and no-FC groups; Supplemental Figure 3). Passage 3 MSCs were induced toward osteogenesis, chondrogenesis, and adipogenesis using standard protocols22 (link)
and toward fibrogenesis, as described previously,31
with the cells allowed to adhere to a circular cover slide placed in the respective culture wells. Fibrogenic cultures were grown in DMEM with 10% FBS, antibiotics, L-ascorbic acid, and recombinant human CTGF (PHG0286; ThermoFisher Scientific, Ottawa, Canada). For osteogenesis and chondrogenesis, we used StemMACS OsteoDiff and ChondroDiff media, respectively (Miltenyi Biotec); adipogenic cultures were grown in DMEM with 10% FCs, antibiotics, 10% horse serum (Stem Cell Technologies, Vancouver, Canada), 0.5 mM isobutylmethylxanthine, 60 μM indomethacin, and 0.5 μM hydrocortisone (all from Sigma). Due to limited tissue sample sizes and available cells, assays were performed in duplicate for each sample, rather than triplicate.
Fibrogenic cultures were stained using Masson trichrome on day 28. Calcium deposits were stained using alizarin red on day 21 as previously described.22 (link)
Chondrogenic pellets were cut into 5-µm sections using the Leica CM1950 cryostat (Leica Biosystems, Nussloch, Germany), fixed and stained with toluidine blue. Adipogenic cultures were stained on day 21 post-induction with oil red O.22 (link)
Differentiation analysis was performed using a standardized method across each differentiated tissue. Differentiated cells from each lineage were assessed by taking standardized digital images of cover slips with adherent differentiated cells from each lineage using the Marlin F080C digital camera (Allied Vision Technologies, Exton, PA, USA) mounted on the photo tube of the microscope and magnified using a 2.5× lens, in addition to the objective lens. Camera software was AVT Smartview 1.5.1. A standardized gray box was then placed beside the standardized digital images as a fixed reference for all samples. The intensity of the differentiated cells relative to the standardized box was then calculated using the ImageJ gel staining intensity function.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Differentiation of Brown-like Adipocytes

2025
10T1/2 cells were obtained from the American Type Culture Collection. 10T1/2 cells were maintained in culture medium (Dulbecco’s modified Eagle’s medium, DMEM) supplemented with 10% of fetal bovine serum (FBS, Thermo Fisher Scientific, # NC0959573) and 1% penicillin/streptomycin (pen/strep, Thermo Fisher Scientific, #15070063). Brown-like adipocyte differentiation was induced by treating confluent 10T1/2 cells with DMEM medium containing 10% FBS, and 1% pen/strep, supplemented with 20 nM insulin (Sigma, #I1507), 1 nM T3 (Sigma, #T2877), 125 μM indomethacin (Sigma, #I7378), 1 μM dexamethasone (Sigma, #D4902), 1 μM rosiglitazone (Sigma, #557366-M), and 0.5 μM isobutylmethylxanthine (Sigma, #I5879). After 48 h of stimulation, the induction medium was removed and a maintenance medium, constituted by DMEM supplemented with 10% FBS, 1% pen/strep, 1 nM T3, and 20 nM insulin, was added and replaced every 2 days.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Murine and Human Cell Culture Protocols

2025
The murine mesenchymal stem cell line, C3H10T1/2, was kindly donated by Prof. Eduardo Domínguez Medina (University of Santiago de Compostela, Spain) and cultured at 37 °C under 5% CO2 in DMEM (4.5 g/L glucose, Corning, USA) containing 10% fetal bovine serum (FBS; Sigma-Aldrich, MO, USA) and 1% penicillin and streptomycin (P/S, Biowest) until differentiation into adipocytes, as previously described [19 (link)]. In brief, differentiation was performed after cell confluence with induction medium [maintenance medium supplemented with 1 µM dexamethasone, 0.5 mM isobutylmethylxanthine, 1 µM rosiglitazone (Sigma-Aldrich, MO, USA), and 5 µg/mL insulin (Actrapid, NovoNordisk)]. Two, four, and 6 days after induction, the medium was replaced with maintenance medium containing 5 µg/mL insulin (Actrapid, NovoNordisk). The accumulation of cytoplasmic triglycerides in these cells was detected by staining with Oil Red O (Sigma-Aldrich, MO, USA).
A high-glucose and high-insulin (HG/HI) insulin resistance, and lipid hypertrophy/insulin resistance cell models were established as described previously [11 (link), 20 (link)]. Briefly, cells were differentiated until day 6, washed three times with PBS, and incubated for 2 h in low-glucose (1 g/L) and serum-free cell culture medium. Cells were then cultured in high glucose (4.5 g/L) and high insulin (100 nM), or with palmitate (500 µM in 2% fatty acid-free BSA [Capricorn Scientific, USA]) or oleic acid [1 mM, conjugated in 0.5 mM fatty acid-free BSA [Capricorn Scientific, USA]) in serum-free medium for 24 h in oleic and HG/HI, and 18 h in palmitate. For vesicle isolation, the treatment was prolonged to 48 h. For pAkt/Akt pathway analysis, cells were washed three times in PBS and stimulated with insulin (100 nM) for 10 min.
The murine macrophages Raw 264.7 cells were cultured in DMEM (4.5 g/L glucose, Lonza) containing 10% fetal bovine serum (Sigma-Aldrich, MO, USA) and 1% P/S (Biowest) at 37 °C under 5% CO2.
Human macrophage THP-1 cells were cultured in RPMI (without L-Glutamine, Lonza) containing 10% FBS (Sigma-Aldrich, MO, USA), 1% P/S (Biowest) and 0.05 mM β-mercaptoethanol at 37 °C under 5% CO2. THP-1 monocytes were differentiated into macrophages by adding 5 µg/mL Phorbol Myristate Acetate (PMA) for 24 h. For RNA extraction, the treatment was performed for 24 h, whereas for the isolation of vesicles in the cell secretome, the treatment was prolonged to 48 h.
The human hepatocytes HepaRG cells were cultured in William’s E medium supplemented with GlutaMAX (Gibco) containing 10% fetal bovine serum (FBS; Sigma-Aldrich, MO, USA) and 1% P/S (Biowest) at 37 °C under 5% CO2. However, before differentiation, HepaRG cells were cultured in proliferation medium [maintenance medium with 5 µg/mL insulin (Actrapid, NovoNordisk) and 0.5 µM hydrocortisone hemisuccinate sodium salt (Sigma-Aldrich, MO, USA) for 6 days, renewing the medium every two days. HepaRG cells were differentiated using differentiation medium [maintenance medium with 5 µg/mL insulin (Actrapid, NovoNordisk), 50 µM hydrocortisone hemisuccinate sodium salt, and 2% dimethyl sulfoxide (DMSO, Thermo Fisher Scientific, Massachusetts, USA)] for 15 days, renewing the medium for the first three days and then every three days. Once differentiated, HepaRG cells were washed twice with PBS and serodeprived for 2 h. The cells were then cultured with high glucose (4.5 g/L) and high insulin (100 nM), with palmitate [500 µM in 2% fatty acid-free BSA (Capricorn Scientific, USA)], oleic acid [1 mM, conjugated in 0.5 mM fatty acid-free BSA (Capricorn Scientific, USA)], or with combination treatment [glucose (4.5 g/L) and insulin (100 nM), 250 µM palmitate (Sigma-Aldrich, MO, USA) in 2% fatty acid-free BSA (Capricorn Scientific, USA) and 0.5 mM oleic acid (Sigma-Aldrich, MO, USA), conjugated in 0.5 mM fatty acid-free BSA (Capricorn Scientific)]. For RNA or protein extraction, the treatment was performed for 24 h, whereas for the isolation of vesicles from the cell secretome, the treatment was prolonged to 48 h.
Murine hepatocyte primary cell culture was obtained by hepatic perfusion of 14-week-old male C57BL/6 mice weighing 20 g following previously described protocols [21 (link), 22 (link)]. Hepatocytes from the perfusion were resuspended in 100 mL of complete medium [DMEM (Gibco) with 10% FBS (Lonza) and 1% P/S (Gibco)], divided into 2 × 50 mL tubes, and centrifuged at 400 rpm (SorvallTM ST16, Fisher Scientific) for 4 min. The pellet was resuspended in 30 mL complete medium and 15 mL 90% Percoll (GE Healthcare) and centrifuged at 500 rpm for 10 min. Subsequently, the cell pellet from both tubes was transferred to a single tube, resuspended in complete medium, and centrifuged three times at 500 rpm for 5 min 3 times. Finally, the pellet of hepatocytes was resuspended in 50 mL of complete medium to analyze cell viability by Trypan Blue staining on slides (Cell Counting Chamber Slides, Invitrogen) for cell counting using the Countess® equipment (Invitrogen). Once the viability of the hepatocytes was obtained, 250.000 cells were seeded in 9.2 cm2 plates (Corning, Thermo Fisher Scientific, Massachusetts, USA) previously treated with collagen (Sigma-Aldrich, MO, USA).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

Isolation and Differentiation of MEFs

2025
MEFs were isolated from SIRT6 WT, TG and KO embryos on embryonic day 13.5, individually. In brief, the skin tissues, but not head, limbs or other organs, were dissected from embryos. And then, tissues were minced and spread in a culture dish containing high glucose DMEM medium supplemented with 10% FBS and 1% penicillin/streptomycin. After 48 h of cultivation, cells and tissues were digested with 0.25% trypsin/EDTA (Corning) for 2 min at 37°C. Digested cells and tissues were passed through a 70‐μm cell strainer and then centrifuged at 1000 × g for 5 min. MEFs pellets were resuspended in complete medium and seeded. MEFs were induced for adipocyte differentiation after reaching 100% confluence. The adipogenic cocktail contains 1‐μM dexamethasone (D4902, Sigma), 5 μg/mL insulin (I9278, Sigma), 0.5‐μM isobutyl methylxanthine (I5879, Sigma) and 1‐μM rosiglitazone (S2556, Selleck) in culture medium [9 (link), 20 ]. The induction lasted for 4 days, during which the medium was changed once. And then, the medium was changed to maintain medium with 5 μg/mL insulin and 1‐μM rosiglitazone for 48 h. Finally, mature adipocytes were maintained in control high glucose DMEM medium or LLC‐conditioned‐medium supplemented with 10% FBS and 1% penicillin/streptomycin for 24 h. TNFR2 antagonist (anti mouse TNFR2/CD120b/TNFRSR1B Neutralizing Antibody, 50128‐RN204, Sino Biological) (12.5 μg/mL) or 20‐μM MDL800 (SML2925, Sigma) were used to treat cells for 24 h. Medium supernatant and cells were collected for further analysis, individually.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

Quantification of cAMP Production

2025
Cyclic adenosine monophosphate (cAMP) production was conducted as previously described (Kim et al. 2023 (link)). Nthy-ori 3-1 and Nthy-ori 3-1_TSHR cells were seeded (1.0 × 106 cells/plate) and cultured in 6 cm plates. The next day, after starvation for 4 h, the cells were stimulated with Thyrogen (Genzyme Therapeutics, USA) or SAFA-TSH at different concentrations in 0.5 mM isobutylmethylxanthine (Sigma-Aldrich, USA) for 15 min at 37°C. cAMP concentrations were measured using a cAMP XP assay kit (Cell Signaling Technology, USA), with each experiment including a standard curve for calculation.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Top 5 protocols citing «isobutylmethylxanthine»

1

Multipotentiality Assessment of BMSCs and ASCs

Differentiation assays were performed to determine the multipotentiality of the BMSCs and ASCs. Adipogenic differentiation of cells was determined using oil red O staining (Sigma-Aldrich) after culturing cells in an adipogenic medium containing 1 µM dexamethasone (Sigma-Aldrich), 500 µM isobutylmethylxanthine (Sigma-Aldrich), 60 µM indomethacin (Sigma-Aldrich), and 5 µg/mL insulin (Sigma-Aldrich) for 3 weeks.
Mineralized colonies resulting from the osteogenic differentiation of cells were visualized with alizarin red S staining (Sigma-Aldrich), after culturing the cells in an osteogenic differentiation medium containing 50 µM ascorbate-2 phosphate (Sigma-Aldrich), 10 mM β-glycerophosphate (Sigma-Aldrich), and 0.1 µM dexamethasone for 3 weeks.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Adipocyte Signaling Pathway Analysis

Antibiotics were purchased from Cellgro (Manassas, VA). U0126, Isoproterenol Hydrochloride, Isobutylmethylxanthine, Dexamethasone, Insulin, Oil Red O, and albumin-bound oleate were purchased from Sigma (St. Louis, MO). 4-HNE, AICAR and Glycerol assay kit were purchased from Cayman Chemical Company (Ann Arbor, MI). Free fatty acid assay kit and cAMP assay kit were purchased from BioVision (Mountain View, CA). LDH assay kit and Triglycerides assay kit were purchased from Thermo scientific (Middletown, VA). CycLex AMPK Kinase assay ELISA kit was purchased from Cyclex (Nagano, Japan). Adenylyl Cyclase Type V Inhibitor, NKY80, H89 and SB203580 were purchased from EMD Millipore (Billerica, MA USA). SP600125 and SQ22536 were purchased from Tocris (Bristol, UK). Rabbit anti-p-PDE3B (amino acid 948) polyclonal antibody was purchased from FabGennix Inc. (Frisco, TX). Rabbit anti-tubulin, actin and PDE3B polyclonal antibody were purchased from Santa Cruz Biotechnology (Dallas, TX). Other antibodies such as rabbit anti-p-AMPK (Thr172), p-HSL (ser563), p-HSL(Ser565), p-P38 (Thr180/Tyr204), p38 polyclonal antibody, rabbit anti-p-PKA (Thr197), AMPK, p-ERK1/2 (Thr202/Tyr204), ERK1/2, JNK monoclonal antibody and mouse anti-p-JNK (Thr183/Tyr185) monoclonal antibody were all purchased from Cell Signaling Technology (Danvers, MA).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Adipogenic Differentiation Assay Protocol

Adipogenic medium was made by supplementing complete DMEM with 10% v/v FCS, 10% v/v horse serum (Stem Cell Technologies, Sheffield, UK), 0.5 mmol/L isobutylmethylxanthine (IBMX), 0.06 mmol/L indomethacin, 50 pmol/L hydrocortisone, 2 mmol/L L-glutamine (all from Sigma) and antibiotics, as previously described (3,4,11,30) . Adipogenic differentiation assays were performed in 24- and 48-well plates, with the use of constant cell seeding density of 4 × 104 cells per cm2. Adipogenic medium was changed twice weekly (one-half media changes) during a 21-day time course, and samples were taken for analysis at different time points as specified below.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

Adipocyte Lipolysis Regulation Assay

3T3-L1 fibroblasts (CL-173) were obtained from ATCC (Teddington, UK) and cultivated in DMEM containing 4.5 g/l glucose and L-glutamine (Invitrogen) supplemented with 10% FCS and antibiotics under standard conditions. Cells were seeded in 12 well plates and two days after confluency medium was changed to DMEM supplemented with 10% FCS containing 10 μg/ml insulin (Sigma-Aldrich), 0.25 μM (0.4 μg/ml) dexamethasone (Sigma-Aldrich), and 500 μM isobutylmethylxanthine (Sigma-Aldrich). After 3 and 5 days, medium was changed to DMEM supplemented with 10% FCS containing 10 μg/ml and 0.5 μg/ml insulin, respectively. On day 7 of differentiation the cells were incubated overnight in the absence of insulin. Cells were used at day 8 of differentiation. For experiments, cells were preincubated with 0, 0.1, 1, 10, or 50 μM of Atglistatin in the presence or absence of 10 μM Hi 76-0079 (NNC 0076-0000-0079, provided by Novo Nordisk, Denmark) for 2 h. Then, the medium was replaced by DMEM containing 2% BSA (fatty acid free, Sigma, St. Louis, MO), 20 μM forskolin, and 0, 0.1, 1, 10, or 50 μM of Atglistatin in the presence or absence of 10 μM Hi 76-0079 for 1h. The release of FA and glycerol in the media was determined using commercial kits (NEFA C, WAKO, free glycerol reagent, Sigma). Protein concentration was determined using BCA reagent (Pierce) after extracting total lipids using hexane:isopropanol (3:2), and lysing the cells using 0.3 N NaOH/0.1 % SDS.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

Adipogenic Differentiation of hBMSCs

HBMSCs were isolated by density gradient centrifugation with Ficoll-Paque (GE Healthcare) and plastic adherence and grown in DMEM (low glucose, Invitrogen) containing 10% fetal bovine serum and 1% antibiotics; cells from passages 3-5 were used experimentally. A published protocol was followed to induce adipogenic differentiation of hBMSCs [26 (link)]. HBMSCs were cultured at a density of 5000~6000 cells/cm2. After reaching confluence, hBMSCs were cultured for one more week and induced in adipogenic medium containing 0.5 mM isobutyl-methylxanthine (Sigma-Aldrich), 1 μM dexamethasone (Sigma-Aldrich), 10 μM insulin (Roche), 100 μM indomethacin (Sigma-Aldrich) for three days and maintained in medium with 10 μM insulin for one day. The treatment was repeated two or three times, after which the cells were maintained in DMEM with 10 μM insulin until day 21 and subjected to oil red O staining to detect cytoplasmic triglyceride.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Find protocols
2. Find best products for an experiment
3. Validate product use from papers
4. Check Product Compatibility
5. Ask a technical question
Want to copy this response? Upgrade to Premium to unlock copy/paste and export options.